Cambium Networks Toekomstige groei
Future criteriumcontroles 1/6
De verwachting is dat Cambium Networks de winst en omzet met respectievelijk 129.1% en 13.6% per jaar zal laten groeien, terwijl de winst per aandeel naar verwachting zal groeien met 129.9% per jaar.
Belangrijke informatie
129.1%
Groei van de winst
129.9%
Groei van de winst per aandeel
Communications winstgroei | 16.6% |
Inkomstengroei | 13.6% |
Toekomstig rendement op eigen vermogen | n/a |
Dekking van analisten | Low |
Laatst bijgewerkt | 12 Nov 2024 |
Recente toekomstige groei-updates
Recent updates
Investors Give Cambium Networks Corporation (NASDAQ:CMBM) Shares A 27% Hiding
Oct 23It's Down 26% But Cambium Networks Corporation (NASDAQ:CMBM) Could Be Riskier Than It Looks
Jul 04Is Cambium Networks (NASDAQ:CMBM) Using Too Much Debt?
May 03Cambium Networks: FY2024 Could Be Another Year Of Pain
Feb 29Analysts Have Made A Financial Statement On Cambium Networks Corporation's (NASDAQ:CMBM) Yearly Report
Feb 18After Leaping 30% Cambium Networks Corporation (NASDAQ:CMBM) Shares Are Not Flying Under The Radar
Dec 27Is Cambium Networks (NASDAQ:CMBM) A Risky Investment?
Nov 08Analysts Just Slashed Their Cambium Networks Corporation (NASDAQ:CMBM) Earnings Forecasts
Oct 10Is Now The Time To Look At Buying Cambium Networks Corporation (NASDAQ:CMBM)?
Sep 16Need To Know: Analysts Just Made A Substantial Cut To Their Cambium Networks Corporation (NASDAQ:CMBM) Estimates
Aug 07Cambium Networks Corporation's (NASDAQ:CMBM) Intrinsic Value Is Potentially 82% Above Its Share Price
Aug 03Here's Why Cambium Networks (NASDAQ:CMBM) Has Caught The Eye Of Investors
Jun 08Is Now An Opportune Moment To Examine Cambium Networks Corporation (NASDAQ:CMBM)?
May 08There Are Reasons To Feel Uneasy About Cambium Networks' (NASDAQ:CMBM) Returns On Capital
Oct 29Cambium Networks (NASDAQ:CMBM) Has A Pretty Healthy Balance Sheet
Oct 05Why Buy Cambium Networks After Q2 2022 Results
Aug 09Return Trends At Cambium Networks (NASDAQ:CMBM) Aren't Appealing
Jul 21Is Cambium Networks (NASDAQ:CMBM) A Risky Investment?
May 28Winst- en omzetgroeiprognoses
Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
---|---|---|---|---|---|
12/31/2026 | 221 | N/A | N/A | -1 | 1 |
12/31/2025 | 208 | -7 | N/A | 25 | 5 |
12/31/2024 | 175 | -52 | N/A | -12 | 4 |
9/30/2024 | 172 | -98 | -24 | -11 | N/A |
6/30/2024 | 172 | -115 | -33 | -20 | N/A |
3/31/2024 | 185 | -108 | -38 | -27 | N/A |
12/31/2023 | 220 | -77 | -28 | -17 | N/A |
9/30/2023 | 264 | -15 | -18 | -7 | N/A |
6/30/2023 | 303 | 21 | -15 | -4 | N/A |
3/31/2023 | 312 | 26 | 0 | 10 | N/A |
12/31/2022 | 297 | 20 | -12 | -3 | N/A |
9/30/2022 | 291 | 12 | -12 | -2 | N/A |
6/30/2022 | 286 | 7 | -3 | 8 | N/A |
3/31/2022 | 309 | 16 | 8 | 18 | N/A |
12/31/2021 | 336 | 37 | 20 | 30 | N/A |
9/30/2021 | 340 | 47 | 31 | 39 | N/A |
6/30/2021 | 337 | 47 | 37 | 44 | N/A |
3/31/2021 | 307 | 39 | 45 | 50 | N/A |
12/31/2020 | 278 | 19 | 52 | 57 | N/A |
9/30/2020 | 260 | 7 | 44 | 48 | N/A |
6/30/2020 | 252 | 3 | 16 | 20 | N/A |
3/31/2020 | 259 | -20 | -4 | 0 | N/A |
12/31/2019 | 267 | -18 | 0 | 4 | N/A |
9/30/2019 | 266 | -16 | -14 | -8 | N/A |
6/30/2019 | 260 | -20 | 0 | 7 | N/A |
3/31/2019 | 251 | 1 | -7 | 0 | N/A |
12/31/2018 | 242 | -2 | -18 | -10 | N/A |
3/31/2018 | 226 | 6 | N/A | 12 | N/A |
12/31/2017 | 217 | 9 | N/A | 23 | N/A |
12/31/2016 | 181 | 2 | N/A | 17 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: De verwachting is dat CMBM de komende 3 jaar verliesgevend zal blijven.
Winst versus markt: De verwachting is dat CMBM de komende 3 jaar verliesgevend zal blijven.
Hoge groeiwinsten: De verwachting is dat CMBM de komende 3 jaar verliesgevend zal blijven.
Omzet versus markt: De omzet van CMBM ( 13.6% per jaar) zal naar verwachting sneller groeien dan de markt US ( 9% per jaar).
Hoge groei-inkomsten: De omzet van CMBM ( 13.6% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Onvoldoende gegevens om te bepalen of het rendement op eigen vermogen van CMBM naar verwachting over 3 jaar hoog zal zijn